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Abstract
Study Design: Literature Review (Narrative).
Objective: To introduce the number 10 research priority for Degenerative Cervical Myelopathy: Individualizing Surgery.
Methods: This article summarizes the current recommendations and indications for surgery, including how known prognostic
factors such as injury time, age, disease severity, and associated comorbidities impact surgical outcome. It also considers key
areas of uncertainty that should be the focus of future research.
Results: While a small proportion of conservatively managed patients may remain stable, the majority will deteriorate over
time. To date, surgical decompression is the mainstay of treatment, able to halt disease progression and improve neurologic
function and quality of life for most patients. Whilst this recognition has led to recommendations on when to offer surgery,
there remain many uncertainties including the type of surgery, or timing in milder and/or asymptomatic cases. Their clariﬁcation
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has the potential to transform outcomes, by ensuring surgery offers each individual its maximum beneﬁt.
Conclusion: Developing the evidence to better guide surgical decision-making at the individual patient level is a research
priority for Degenerative Cervical Myelopathy.
Keywords
degenerative cervical myelopathy, cervical spine, cervical spondylotic myelopathy, myelopathy, spondylosis, nontraumatic spinal
cord injury

Introduction
Degenerative Cervical Myelopathy (DCM) refers to symptomatic dysfunction of the spinal cord resulting from acquired
stenosis of the cervical spinal canal secondary to degenerative
changes in several spinal structures. These include spondylosis, disc herniation, and facet arthropathy (collectively referred to as cervical spondylotic myelopathy) or ligamentous
abnormalities, ossiﬁcation of the posterior longitudinal ligament (OPLL), and hypertrophy of the ligamentum ﬂavum.
With an estimated annual incidence of 41 per million in North
America, DCM is the most common cause of spinal cord
dysfunction worldwide.1 It is characterized by a triad of
symptoms-gait imbalance, loss of hand dexterity, and
sphincter dysfunction.2 Other symptoms are neck pain or
stiffness, upper limb pain, weakness and paresthesias, lower
limb stiffness, weakness, or numbness.
Over the last several decades, our knowledge of the
natural history of DCM and the understanding of the beneﬁts
of surgical intervention has evolved. As the literature has
become more sophisticated, multiple sources of information
have conﬁrmed that patients with DCM treated nonoperatively may decline and lose their clinical and functional status. In a seminal study published in 1956, Clarke
and Robinson analyzed 120 patients with DCM and characterized the natural history of the disease as consisting of a
progressive stepwise functional decline in 75% of patients; a
slow, steady decline in 20% of cases; and a rapid onset of
symptoms followed by a long period of remission (up to
14 years) in 5% of patients.3 More recent evidence shows that
while a small proportion of patients may remain stable over
the years, the majority will deteriorate if left untreated. A
2013 systematic review found that 20–62% of DCM patients
treated non-operatively will exhibit clinical deterioration at
3–6 years.4 Data from other studies indicates that 23–54% of
patients treated non-operatively will require decompression
at a mean of 29–74 months5-7 due to progression of the
disease. Furthermore, recent evidence shows that surgery for
DCM is associated with improved function and quality of
life. A prospective AO Spine North America study including
278 patients with mild, moderate, and severe DCM found a
signiﬁcant improvement in the modiﬁed Japanese Orthopaedic (mJOA) score, Nurick grade, Neck Disability Index
(NDI), and all SF-36v2 subscales at 1 year after surgery and

the degree of improvement was independent of the severity
of the pre-operative symptoms (except for the mJOA score,
in which patients with more severe symptoms improved the
most).8 This ﬁnding was later conﬁrmed in a global study
including 479 DCM patients from 16 centers across the
world with a 24 -month follow-up, with varying degrees of
disease severity and etiology and with the surgical approach
being left to the discretion of the surgeon, in which surgery
was found to improve functional status and quality of life
with a neurologic complication rate of 3.13%.9 Considered
together, this evidence indicates that while not all patients
with DCM will require surgery, surgery can not only halt
disease progression but also potentially improve patient
neurologic function and quality of life.
AO Spine RECODE-DCM (aospine.org/recode) [REsearch objectives and COmmon Data Elements for DCM] is an
international consensus initiative, which aims to accelerate
knowledge discovery that can improve outcomes by developing
a set of research tools.10 It included a James Lind Alliance
research priority setting partnership, which brought together
individuals working on and individuals living with DCM, to
establish the most important unanswered questions. Individualizing surgery as deﬁned by the questions “Are there clinical
and imaging factors that can help a surgeon select who should
undergo surgical decompression in the setting of DCM? At
what stage of the disease is surgery the preferred management
strategy?” was deﬁned as research priority number 10.
The objective of this paper was to perform a narrative
literature review to (1) identify factors to assist surgeons in
selecting who should undergo surgical decompression in the
setting of DCM and (2) at what stage of the disease is surgery
the preferred management strategy.

Current Recommendations for Surgery
A frequently used system to categorize and characterize the severity of DCM is the mJOA score. This is an 18-point ordinal score
used to evaluate upper extremity motor function (5 points), lower
extremity motor function (7 points), sensation (3 points), and
micturition (3 points). A maximum score of 18 points occurs in the
absence of neurologic impairment, and a lower score indicates a
greater degree of disability and neurological impairment. Patients
are classiﬁed into mild (15–17 points), moderate (11–14 points),
and severe (≤11 points) DCM.11
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In 2017, Fehlings et al.12 developed 5 evidence-informed
medical guidelines following the GRADE process based on
the (1) natural history of DCM; (2) risk factors for disease
progression; (3) efﬁcacy, effectiveness, and safety of nonoperative and surgical management; (4) impact of preoperative duration of symptoms and myelopathy severity
on treatment outcomes and (5) frequency, timing, and predictors of symptom development.12 These guidelines produced clinical recommendations for the management of this
disease (Table 1).
According to these guidelines, surgical intervention should
be performed on patients with moderate and severe DCM and
those with progressive disease.12 Patients with severe DCM
had improvements in JOA/mJOA, NDI, Nurick, and VAS
scores at short, medium, and long-term follow-up. The cumulative incidence of adverse events was 14.1%, with the
most frequent being axial pain (5.6%), laryngeal nerve injury/
dysphagia (2.2%), instrumentation/graft complication (2.0%)
and C5 radiculopathy or palsy (1.9%) and low pooled cumulative incidences of dural tear/cerebrospinal ﬂuid leak,
worsening of myelopathy, death, pseudoarthrosis, and implant
complications. This systematic review identiﬁed only 1 study
that reported on surgery for moderate DCM patients.8 According to that study, surgery was associated with signiﬁcant
improvements and minimal clinically important differences in
mJOA, NDI, and Nurick scores at short, medium, and longterm follow-up. The rate of surgical complications in patients
with moderate DCM such as C5 radiculopathy or palsy, infection, dural tear or cerebrospinal ﬂuid leak, worsening of
myelopathy, death, pseudoarthrosis, and implant complications was low or very low. For patients with mild DCM,
however, the evidence gathered was deemed to have less rigor
with the majority of the identiﬁed studies being retrospective

case series with only one low-quality randomized controlled
trial analyzing conservative treatment and only 1 study analyzing surgical treatment and stratifying patients according to
DCM severity.13,14 As such, the guidelines recommended
offering surgical treatment or a trial of supervised rehabilitation in patients with mild myelopathy. In the event of clinical
deterioration during the course of conservative treatment, the
authors strongly recommended that surgical treatment should
be offered expeditiously. For non-myelopathic patients with
imaging evidence of spinal cord compression (asymptomatic
cervical stenosis) but without symptoms of radiculopathy, and
since only 22.6% of patients develop myelopathy15 the
guidelines recommend serial observation and not offering
prophylactic surgery. The presence of clinical and/or electrophysiological evidence of radiculopathy, however, should
be a clinical predictor of early (≤12 months) surgical intervention.15 This recommendation should be a shared decision
between the surgeon and the patient. Patients should be offered either a trial of non-operative treatment or surgery;
again, in the event of clinical deterioration, patients should be
counseled and offered surgical treatment.
These guidelines supported that surgery was effective in
improving function in patients with severe and moderate
DCM, but the evidence gathered for patients with mild DCM
had less quality, and the recommendations were therefore
weaker. Since then, additional studies have investigated the
impact of surgery in mild DCM. Badhiwala et al.16 concluded
from an analysis of 193 patients with mild DCM, that DCM
patients had signiﬁcant impairment of their baseline quality of
life compared to the normal population, which was greatest for
social and physical functioning and mental health. Two years
after surgery, the same patients exhibited signiﬁcant improvement in their status, as assessed by the mJOA, NDI, and

Table 1. Clinical Practice Guideline for the Management of Patients with Degenerative Cervical Myelopathy.
DCM Severity

Recommendation

Severe DCM (mJOA score ≤11)
Moderate DMC (mJOA score 12–14)
Mild DCM (mJOA score 15–17)

Surgical intervention
Surgical intervention
Surgical intervention or a supervised trial of
structured rehabilitation. If non-operative
management fails or patients worsen, surgical
intervention should be offered
Counseling on potential risks of progression,
educating about relevant signs and symptoms of
myelopathy and clinical observationa

Non-myelopathic patients with imaging
evidence of cervical spinal cord
compression and without symptoms of
radiculopathy
Non-myelopathic patients with imaging
evidence of cervical spinal cord
compression and with symptoms of
radiculopathy

Quality of
Evidence

Strength of
Recommendation

Moderate
Moderate
Weak

Strong
Strong
Very low to low

Weak

No identiﬁed evidence;
based on clinical expert
opinion

Surgical intervention or non-operative treatment Weak
consisting of close serial follow-up or a
supervised trial of structured rehabilitationa

Low

1. Fehlings MG, Tetreault LA, Riew KD et al. A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Non-myelopathic Patients With Evidence of Cord Compression. Global Spine J 2017;
7: 70S-83S DOI: 10.1177/2192568217701914
a
If myelopathic symptoms develop patients should be managed according to DCM severity.
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Physical and Mental Health SF-36 sub-scores.16 Unfortunately, high-quality randomized controlled trials addressing
this speciﬁc population of DCM patients are lacking; there is
considerably more evidence concerning severe and moderate
than mild DCM. However, it appears that DCM patients are
signiﬁcantly impaired by their disease and that surgery is
associated with improvement of quality of life with minimal
complications.

Prognostic Factors
While effective in halting disease progression, surgical
treatment outcomes are still difﬁcult to predict, with some
patients showing a signiﬁcant improvement in clinical scores
after surgery and others showing little improvement after
surgery. However, some evidence exists that clinical, imaging,
and electrophysiological data may help predict surgical outcomes and aid in decision-making.

Timing of Surgery
Timing of intervention is one of the most critical aspects of
managing DCM. Since DCM is a progressive injury to the
spinal cord, patients with a longer duration of symptoms may
already have a burden of irreversible spinal cord injury (ischemia, neuroinﬂammation, demyelination, and apoptosis of
neurons and oligodendrocytes17), therefore hindering symptomatic improvement with surgery.18 While no deﬁnitive
cutoff has been established, several authors have found lower
JOA recovery rates,19 lower minimum clinically important
differences in mJOA scores,20,21 and less improvements in
Nurick score22,23 when patients were operated on after
12 months from the onset of symptoms.

Age
There is little consensus as to whether age is a predictor of clinical
outcome after surgery for DCM. In a systematic review, Tetreault
and colleagues found no correlation between age and clinical
outcomes, as assessed by the mJOA and Nurick scores.24 Other
studies, however, such as a prospective multi-center AO Spine
International study that included 479 patients25 report that patients greater than 65 years old, while having signiﬁcant beneﬁt
with surgery, had lower mJOA and Nurick scores 24 months after
surgery. Frailty, which refers to a loss of reserves (energy,
physical ability, cognition, health) is a better assessment of a
patient’s physiological age and recent studies have shown to be a
better predictor of mortality, perioperative complications and
functional outcome than age.26,27
Importantly, elderly/frail patients still beneﬁt and should be
considered candidates for surgery, but the beneﬁt may not be
as relevant as in younger/less frail patients. There are several
potential explanations for the reduced functional recovery in
older patients: (1) DCM is usually a degenerative disorder, and
older patients may have more substantial degenerative
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changes, requiring a more complex surgery; (2) Older patients
often have more associated comorbidities which may increase
the rate of medical complications after surgery; (3) Older
patients may have other musculoskeletal comorbidities (osteoarthritis) which may impact their clinical scores, such as
walking distance, regardless of the neurologic recovery after
DCM surgery.
In conclusion, frailty, more than age, may impact on the
mortality, perioperative complications and functional outcome
after DCM surgery. This should be taken into account when
proposing patients to surgery.

Baseline Disease Severity
Pre-operative DCM severity is a predictor of surgical outcomes. In a study of 145 patients who underwent ACCF and
followed for 5 years, those with initial JOA scores ≤ 9 were
4.85 times more likely to have less than a 50% recovery rate
than those with JOA scores above 9.28 In two other studies that
analyzed 4529 and 6430 patients submitted to laminoplasty, the
authors also found that higher JOA scores (together with
younger age) were also associated with improved surgical
outcomes. Tetreault and colleagues31 proposed that a mJOA
score of 12 as a threshold below which patients are expected to
have less improvement with surgery.31

Comorbidities
Several studies have analyzed the inﬂuence of patient comorbidities on postoperative outcomes, with diabetes being
the most frequently reported. Lower postoperative scores have
been found in diabetic patients compared to non-diabetic,32
and also in diabetic patients diagnosed longer than 10 years
previously and in patients with HbA1c levels ≥ 6.5%.19
Additionally, in an analysis of 113 DCM patients, Kusin
et al.33 identiﬁed a strong correlation between higher perioperative glucose levels and lower postoperative Nurick
scores, suggesting that high glucose levels indicate greater
morbidity.33 Smoking is another comorbidity that has been
identiﬁed as a prognostic factor, and studies suggest that
smoking status is associated with lower postoperative Nurick
and mJOA scores.20,34 In isolation, comorbidities such as
kidney disease, respiratory, rheumatologic cardiac, and psychiatric diseases have not shown an association with postoperative clinical scores.19,20

Imaging
Imaging studies are critical for diagnosing and planning DCM,
and to predict prognosis after surgery. MRI is almost universally used to assess the degree and anatomic location of spinal
cord compression. A region of intramedullary hyperintensity
seen on T2-weighted images is identiﬁed in 58-85% of DCM
patients and was correlated with clinical impairment.35 The T2
signal hyperintensity in established DCM commonly has a
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clear border, representing tissue loss and gliosis, which is
associated with a more limited surgical outcome.35,36 In more
acute and rapidly progressing cases, the T2 hyperintensity
may be difﬁcult to discern and not well-circumscribed, indicating edema and evolving Wallerian degeneration, which
may be reversible with surgery. Hypointensity on T1weighted images is associated with worse baseline neurologic impairment and more permanent irreversible injury,
even with surgery.37,38
Standing radiographs are used to evaluate cervical spine
alignment, whereas ﬂexion-extension X-rays can be used to
assess instability, which may cause dynamic spinal cord
compression.25 OPLL or ossiﬁcation of the ligamentum ﬂavum is better identiﬁed on CT-scans. CT myelography may be
used when MRI is contraindicated (such as in patients with
pacemakers) to provide direct visualization of the spinal cord
and canal relationship.39

Surgical Decision-Making in DCM
The goal of surgical treatment for DCM is to arrest progression
by decompressing the spinal cord and aligning and stabilizing
the spine. The preferred approach will depend on patient
factors, imaging features, and the sources of spinal cord
compression. In appropriate patients, surgical decompression
and reconstruction of the cervical spine can be performed via
anterior, posterior, or combined (anterior and posterior approaches) with comparable effectiveness and safety40
(Table 2). Typically, anterior surgery is reserved for cases
with a predominant ventral compression, at 1 or 2 levels, and
in patients with cervical kyphosis. Posterior surgery has been
used for patients with OPLL and with multisegmental pathology in patients with preserved lordosis. Surgical decisionmaking, however, is nuanced, and surgeons must consider
factors such as cervical spine alignment, the number of motion
segments involved, morphology, and location of the spondylotic compression, in order to adequately decompress the
spinal cord while reducing complications and optimizing
outcomes. When properly indicated, anterior and posterior
surgery achieve comparable results as assessed by the mJOA,
Nurick, NDI, and SF-36, with similar complication rates.41 At
the same time, there is low-quality evidence that neck pain
may be less after anterior surgery and moderate evidence that
posterior surgery may achieve an increased spinal canal
diameter.40
The most commonly used anterior approaches are anterior
cervical discectomy and fusion (ACDF), anterior cervical
corpectomy and fusion (ACCF), hybrid ACDF/ACCF constructs, and cervical disc replacement. In patients with multilevel disease and when an anterior surgery is performed,
multiple ACDF, ACCF, or hybrid discectomy-corpectomies
may be performed. When possible, multilevel ACDF
(Figure 1A) should be preferred, as it has shown to be best at
achieving sagittal correction and yielding lower pain scores
with similar incidences of non-union, dysphagia, and infection
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than the alternatives.42 However, if there is signiﬁcant retrovertebral compression, an ACCF (Figures 2B and 2C) or
hybrid ACCF-ACDF should be performed to decompress the
spinal cord adequately. When possible, hybrid constructs
should be preferred to multiple corpectomies, as they have
been shown to achieve similar neurologic improvement but
better sagittal correction and improvement in neck pain.42 The
improved sagittal correction and spine biomechanics may also
aid in reducing the long-term incidence of adjacent segment
disease.43
While restriction of motion was thought to be one of the
cornerstones of myelopathy treatment, concerns about motion
preservation and reducing adjacent level degeneration after
anterior cervical fusions have prompted the study of the effectiveness of total disc replacement in myelopathy patients.
Results of these studies, some with 10 years of follow-up, have
shown clinical improvement of patients treated with disc
replacement, as assessed by the JOA and NDI scores with no
differences in complication rates to patients treated for radiculopathy or to patients treated with ACDF.44-46 Furthermore,
a recent systematic review comparing ACDF with cage and
plate, ACDF with stand-alone cage, and cervical disc replacement found no differences in NDI scores and in sagittal
alignment. As such, and while cervical disc prostheses are not
traditionally considered lordosis-producing devices, the
amount of lordosis achieved is comparable to that which is
achieved with ACDF.47
Posterior surgery relies on a passive decompression or the
“drift back” phenomenon of the spinal cord drifting away from
the anterior compression sites. Therefore, it has a limited effect
in a kyphotic cervical spine. The modiﬁed k-line48,49 is a line
connecting the midpoints of the spinal cord at C2 and C7 on
pre-operative T1-weighted sagittal magnetic resonance imaging and is a useful predictor of the ability of posterior
surgery to sufﬁciently decompress the spinal cord. If the
distance between the anterior compression and the k-line is
lower than 4 mm, posterior surgery will not allow for sufﬁcient
cord shift and an appropriate decompression, and an anterior
surgery is recommended.50
Historically, when opting for a posterior approach, multilevel laminectomies were often performed. This procedure,
however, has been associated with progressive kyphosis in 15–
20% of patients,51 which led to the progressive abandonment of
this procedure. Currently, the main posterior surgical approaches are laminectomy and fusion (Figure 2A) and
laminoplasty (Figure 2B). Several authors have attempted to
compare these procedures, and while well designed randomized controlled trials are still lacking, current evidence
indicates that laminectomy alone may lead to inferior outcomes when compared to laminectomy and fusion.52 In
particular, this retrospective analysis of prospectively accrued cohort data demonstrated signiﬁcant differences
between surgical cohorts in the change in mJOA and Nurick
scores from pre-operative to 24 months postoperative
(mJOA: 1.70, P = .0266; Nurick: .90, P = .0241). The
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Table 2. Indications for surgical approach to DCM based on imaging and clinical ﬁndings. PCDF: posterior cervical decompression and fusion;
ACDF: anterior cervical discectomy and fusion; ACCF: anterior cervical corpectomy and fusion; STV: subtotal vertebrectomy; OPLL:
ossiﬁcation of the posterior longitudinal ligament.
Surgical Approach
Variables
Imaging
ﬁndings

Level of
compression
Single-level
disease
Multiple level
disease (≥ 3)

Anterior Posterior Combined Surgical Procedure Comments
Occiput-C2

+

Anterior compression
Posterior compression
Retrovertebral disease
Anterior or posterior
compression
Retrovertebral
Minimal
disease
disease

+
+
+
+
+

Signiﬁcant
disease

Clinical
ﬁndings

PCDF

+

+
+

ACDF
Laminoplasty, laminectomy, and fusion
ACCF, STV
Similar Effectiveness and safety between
anterior approaches
In anterior approach, multiple
discectomy > corpectomy or
discectomy-corpectomy hybrid
procedures
In anterior approach, discectomycorpectomy hybrid approaches >
multiple corpectomies

Stenotic segments (<3)
Congenital
Single-level disease
stenosis
Multiple level disease
Alignment
Neutral or lordotic
Kyphotic (> 13°)
Modiﬁed K-line (+)
Modiﬁed K-line ( )
OPLL

+
+
+
+
+

OPLL and canal occupancy ratio >60%

+

+

Instability
Myeloradiculopathy + soft-disk herniation

+
+

+

Myeloradiculopathy + spondylotic foraminal
stenosis
Axial neck pain

+

+

+

+

ACDF, laminectomy and fusion, or
combined
Laminoplasty
Laminoplasty, laminectomy ± fusion

+

Laminoplasty or combined

Previous radiation around the neck
History of dysphagia, dysphonia, or vocal
occupation
Chronic smoker

rate of perioperative complications was comparable (P =
.879). A randomized controlled trial entitled “Fusion 4
DCM” and aiming to enroll 394 patients is due to start in
2021 and will be comparing laminectomy with laminectomy
with fusion (NIHR131243).
Laminoplasty is a procedure to expand the spinal cord size
without a requirement for fusion and with the potential to preserve
posterior spinal structures.53 Studies comparing laminoplasty with
laminectomy and fusion indicate that both procedures achieve
similar clinical improvements but that laminectomy and fusion may
be associated with longer operative times and higher complication
rates,54 including neck pain and C5 palsy55 and with higher associated costs.56 Conversely, laminoplasty may be superior to
laminectomy in preserving cervical ROM, pre-operative cervical
lordosis, and minimizing neck disability.57

+
+
+

+
+

Laminectomy and fusion or laminoplasty
+
+
+
+
+

If anterior approach is used: ﬂoating
method
If anterior approach is used: ACDF, STV,
ACCF
ACDF, laminectomy, and fusion
ACDF or posterior decompression ( ±
fusion) + foraminotomy

Surgical management of DCM secondary to OPLL can be
particularly challenging. In contrast to DCM secondary to
spondylosis, in which compression is usually at the level of the
intervertebral disc, in OPLL compression often also occurs at the
level of the vertebral body. As such, an anterior approach to these
patients may require corpectomy rather than multiple discectomies. However, dissection of the ossiﬁed ligament from the
dural sac is challenging and risky and, therefore, a posterior
approach has been often proposed to manage these patients and
studies have shown it is safer and may achieve equivalent decompression.58 When performing a posterior approach laminectomy and fusion should be preferred to motion-preserving
techniques, such as laminoplasty, since the later have been shown
to have a 7 times faster mean postoperative annual OPLL growth
rate.59 For patients with OPLL occupying >60% of the spinal
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Figure 1. Anterior surgical options for DCM. (A) Lateral cervical x-ray view and (B) sagittal CT-scan view of a patient submitted to C6
corpectomy and C5-C7 fusion with autograph and plate. (C) Latera cervical x-ray view of a patient submitted to C3-C4 and C4-C5 anterior
cervical discectomy and fusion (ACDF) with cages.

severity (lower mJOA scores) is found in patients with preoperative sagittal imbalance.55,68 Surgical correction of
sagittal imbalance provides a greater degree of neurologic
improvement, a lower degree of axial pain,69,70 and lower
postoperative disability scores.71 Furthermore, correcting sagittal imbalance potentially reduces the degeneration of adjacent
levels, further improving the long-term results of surgery.

Proposing Surgical Treatment to DCM
Patients Being Managed Conservatively/Mild
DCM Patients who should be Proposed for
Surgical Treatment
Figure 2. Posterior surgical options for DCM. (A) Posterior
decompression and fusion with lateral mass screws. (B)
Laminoplasty.

canal, an anterior approach is however associated with better
neurologic recovery and should be the preferred approach.60,61
Over the last decades, alternative approaches have been
proposed to decompress the spinal cord through a posterior
approach. One such procedure is skip laminectomies, where
the spinal cord is decompressed in regions of greater stenosis
but with preservation of the posterior tension band, therefore,
theoretically reducing the incidence of postoperative kyphosis
and yet avoiding fusion. A 2018 meta-analysis comparing it
with laminoplasty reported lower VAS scores and rate of axial
pain and muscle atrophy for skip laminectomies in patients
with comparable cervical lordotic curvature and range of
motion.62 Tubular/minimally invasive approaches have also
been proposed as less invasive alternatives63-65 and while the
indications may be more restricted and high-quality evidence
is still lacking, small comparative studies of selected patients
have reported favorable results.66,67
As aforementioned, restoring the sagittal spine balance is
one of the goals of myelopathy surgery. Greater myelopathy

Non-operative management of DCM is poorly deﬁned in the
literature, and while structured non-operative treatment has
not been associated with any direct harms, there is also little
evidence of its beneﬁts, with most studies reporting changes in
mJOA below the minimal clinically important differences. Of
those patients initially managed conservatively, 23–54% require surgical treatment at 29–74 months.72 Due to this lack of
proof of clinical improvement with non-operative treatment
and to the high conversion to surgical treatment, it is imperative that patients with DCM potentially eligible for initial
conservative management are also referred for surgical assessment, as reports show that delay of surgical treatment is
predictive of worse surgical outcome.
Importantly, while non-operative management may be
pursued in some patients, when the disease is progressive,
surgery should always be discussed, irrespective of baseline
disease severity.12 Regardless of disease severity, patients with
circumferential cord compression on axial MRI, “angularedged” spinal cord, greater head and cervical range of motion,
lower segmental lordotic angle and a greater percentage of
vertebral slip, segmental instability, and reduced diameter of
the cerebrospinal ﬂuid column are at higher risk of DCM
progression and should be submitted to surgical treatment.72
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Areas of Uncertainty
Mild Myelopathy
Whilst improvements have been demonstrated in patients
undergoing surgery for mild DCM,8 it remains controversial.
In particular, the prospect that symptoms may remain stable
for prolonged time periods makes surgical decisions difﬁcult.3
On the other hand, surgery on the strata of patients whose
symptoms will progress should prevent future disability.
Reﬂecting this uncertainty, current surgical guidelines remain
vague and imply an expectant approach until a clear deterioration is observed. A better understanding of the natural
history of myelopathy and the risk factors for deterioration
would enable early patient selection and triage for surgery.

Atypical Symptoms
DCM is characterized by a triad of symptoms encompassing
gait imbalance, loss of hand dexterity, and sphincter dysfunction. These may appear together or separately and frequently are associated with cervical pain. Of importance for
diagnosticians, some studies have highlighted the relevance of
atypical presentation of DCM, which may further delay the
initial diagnosis, referral, and appropriate treatment. Kobayashi
et al. found that DCM patients reported chest tightness 22.9
times more often than non-myelopathic patients,73 resulting in
inclusion as one of the symptoms to be queried in an 8-item
questionnaire for DCM screening. Mowforth et al.74 reported a
patient with sensory dysesthesia, including facial dysesthesia
secondary to DCM with typical gait, dexterity, and sphincter
symptoms that were only linked to DCM after 11 visits to the
emergency department.74 Oh et al.75 reported a patient with
DCM in which a megacolon only resolved after surgical decompression of the cervical stenosis.75 Houten et al. reported a
series of 12 DCM patients presenting without upper extremity
symptoms76 that all reported gait difﬁculty; more than half had
objective lower extremity weakness. Sensory examination revealed disturbances below the cervical compression level,
starting at the mid-thoracic, waist, or genital area.76 These
reports may indicate complex symptomatic patterns resulting in
myelopathy together with dysregulation of other systems.

Neurophysiology
Electrophysiological studies (motor and sensory evoked potentials) have been widely used in the assessment of DCM as
well as in the differential diagnosis with neurodegenerative
disorders. The magnitude of evoked potential abnormality
often correlates with the magnitude of DCM severity77 and
may predict surgical outcomes. Importantly, evoked potentials
may be particularly useful at early DCM stages, where the
disease can be more difﬁcult to diagnose, and pyramidal signs
are still absent.78
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Intraoperative neurophysiological monitoring (including
transcranial evoked muscle action potentials) is important to
ensure that a worsening of conduction is not caused by reduced blood pressure or surgical maneuvers such as distraction. If the spine will be positioned other than in neutral, it
is important to obtain a set of evoked potentials before the ﬁnal
operative neck position is set.79

Dynamic Imaging and Myelopathy Without Visualized
Spinal Cord Compression
Some patients may even present with DCM symptoms
without spinal cord compression visible on conventional
static MRI. In such cases, dynamic MRI (performed with the
neck in ﬂexion and extension) may help to identify spinal
cord compression in patients where it could otherwise be
missed. Reporting the analysis of a cohort of 2471 patients,
Hayashi et al.80 identiﬁed missed dynamic compression in
cervical extension in 8.3% of patients, and in 1.6% of patients in ﬂexion, with the most frequently missed level being
C5–C6. Lee et al.81 reported that cervical canal diameter was
more signiﬁcantly reduced in dynamic MRI of patients with
DCM from degenerative/spondylotic changes rather than
that resulting from OPLL. Nigro et al.82 suggested that
dynamic MRI was more useful for diagnosing posterior
compression, whereas anterior compression was more often
diagnosed with static MRI.
Disc bulge greater than 2.4 mm, angular motion greater
than 4.8°, moderate and severe disc degeneration, segmental
kyphosis, and developmental stenosis are more commonly
evident in extension dynamic MRI than with static MRI,
whereas disc bulge greater than 1.9 mm, moderate to severe
disc degeneration and segmental kyphosis are more commonly found in ﬂexion dynamic MRI and missed with conventional MRI.80 Together, these observations indicate that
the position in which the images are acquired may inﬂuence
the magnitude of DCM spinal pathology.

Microstructural MRI as an Imaging Biomarker
Emerging evidence indicates that microstructural MRI approaches, including the use of T2-weighted imaging, can
detect neuroanatomical changes in the cord of patients with
DCM,83 which are predictive of baseline impairment and risk
for myelopathic progression. Future work is required to extend
and validate this promising work. Microstructural MRI holds
promise as an imaging biomarker that could add precision to
clinical decision-making on which patients with mild DCM
are at the highest risk for disease progression. Moreover, this
technology could assist with clinical prediction assessment to
help with patient education as to the anticipated course of their
disease.84
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Conclusion
This report highlights the available evidence on the surgical
management and outcomes of DCM. There is presently very
little data to support the conservative management of DCM.
Surgical treatment of these patients can halt disease progression and reverse some disease symptoms and improve
patient quality of life. The risks of surgery and comorbidities
need to be balanced against the risks of disease progression
and irreversible neurologic damage. A thorough understanding of individual disease stages and related prognostic
factors should guide an individualized treatment plan aiming
to appropriately and timely address disease symptoms. The
main challenge remains to identify patients at a sufﬁciently
early disease stage where the neurologic injury may be less
progressed, and the likelihood of improvement with surgery
is optimized. Future studies are needed to systematically
analyze disease-speciﬁc factors in the context of individual
variables such as age, sex, and comorbidities, together with
integrated clinical, radiographic, electrophysiological, and
other related data to determine in whom and when surgery
should occur and to tailor surgery to achieve the best
outcomes.
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